Vitamin D status in children and young adults with perinatally acquired HIV infection.
To assess vitamin D (Vit-D) [serum 25-hydroxyvitamin D (25-OHD) concentrations] in children and young adults with perinatally acquired HIV compared to geographically similar healthy children. 25-OHD in children and young adults with HIV was compared to a healthy group. Vit-D deficiency and insufficiency were defined as 25-OHD <11 ng/mL and 25-OHD <30 ng/mL, respectively. Children with HIV (n = 81), mean age 13.8 ± 4.1 years, 48% female, 83% Black, were compared to healthy subjects (n = 372), mean age 12.4 ± 3.4 years, 51% female, 37% Black. For the HIV group, 84% were on HAART, 54% had plasma HIV RNA <400 cpm, and 35% had moderate to severe immunosuppression (CD4+ count <500 cells/mm). Vit-D deficiency/insufficiency was present in 36% and 89% of those with HIV, and 15% and 84% of the comparison group, respectively. Vit-D deficiency was more prevalent in those with HIV (unadjusted odds ratio: 3.25; 95% CI: 1.9-5.5). For both groups, prevalence of Vit-D deficiency increased with age, BMI Z-score, Black race, and in winter/spring months. Vit-D deficiency was associated with a greater degree of immunosuppression in the subjects with HIV. Vit-D deficiency was increased in subjects with perinatally acquired HIV and may be associated with disease severity.